pmed.1003691.s004.tif (679.7 kB)
Kaplan–Meier curves for the primary endpoint of progression to microalbuminuria according to treatment with or without ACE inhibitor (A) and with or without ARB (B).
figure
posted on 2021-07-14, 17:26 authored by Piero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, Matias Trillini, Ilian P. Iliev, Antonio C. Bossi, Antonio Belviso, Maria C. Aparicio, Roberto Trevisan, Stefano Rota, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Silvia Prandini, Flavio Gaspari, Fabiola Carrara, Salvatore De Cosmo, Giancarlo Tonolo, Ruggero Mangili, Giuseppe RemuzziACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker.
(TIF)
History
Usage metrics
Categories
Keywords
microalbuminuriaRASBPACEacceleration factors612 type 2combination therapybenazeprilVARIETYvalsartannormoalbuminuric type 2failure time modelIstituto di Ricerche Farmacologiche...angiotensin receptor blockersCIcombination therapy groupstudy Background AngiotensinmgPROBEIQRClinicalTrials.gov NCT 00503152Trial registration EudraCT 2006-005...high-normal albuminuriaARBmonotherapy
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC